Read all the news of the independent investment banking dedicated to Growth
Having completed its IPO roadshow, closed books, and established the official IPO price, Symetis, the leading European structural heart player, received a definitive, all-cash offer from Boston Scientific to purchase the Company
Welcome to Bryan, Garnier & Co’s March 2017 Healthcare newsletter
Welcome to the first in a new series of “Market Watch" reports about the Automotive sector
Enter your email to receive our news and offers.